Literature DB >> 10665485

Congenital muscular dystrophy with rigid spine syndrome: a clinical, pathological, radiological, and genetic study.

K M Flanigan1, L Kerr, M B Bromberg, C Leonard, J Tsuruda, P Zhang, I Gonzalez-Gomez, R Cohn, K P Campbell, M Leppert.   

Abstract

Rigid spine syndrome is a term first proposed by Dubowitz to describe a subset of patients affected by myopathy with early spinal contractures as a prominent feature. While spinal rigidity is a nonspecific feature, found in Emery-Dreifuss muscular dystrophy and in some congenital myopathies, it is also a prominent feature in a group of patients with merosin-positive congenital muscular dystrophy, where it is generally associated with stable or only slowly progressive weakness and early respiratory insufficiency. Recently, the first locus for congenital muscular dystrophy in association with rigid spine syndrome was mapped to chromosome 1p35-p36 in consanguineous Moroccan, Turkish, and Iranian families. We present here a detailed phenotypic description of the familial syndrome linked to this locus, describing 4 siblings (3 boys and 1 girl) of Northern European-American heritage who are the offspring of a nonconsanguineous marriage. All 4 siblings were affected by hypotonia and prominent neck weakness in infancy, early spinal rigidity, and early scoliosis. After initial improvement, muscle strength stabilizes or slowly declines, and skeletal deformities and respiratory insufficiency supervene. Muscle biopsy in an affected child at age 9 months revealed minimal, nonspecific myopathic changes, leading to a diagnosis of "minimal change myopathy." Muscle biopsy in his sibling, at the age of 14 years, revealed chronic and severe myopathic (dystrophic) changes, with normal staining for laminin-2 and for proteins of the dystrophin-glycoprotein complex. A possible explanation for these biopsy findings is that magnetic resonance imaging of the thighs reveals stereotyped selective muscle involvement, with the selectivity more pronounced early in the disease course followed by widespread muscular signal abnormalities in the late stages of the disease. In this family, linkage to the chromosome 1p rigid spine syndrome locus (RSMD1) is supported by maximum LOD scores for several markers of 1.81 at theta = 0, representing the maximum statistical power possible for this family. In combination with the previous report, this syndrome is linked to the RSMD1 locus with a summated maximum LOD score of 6.29, and analysis of recombination events in our family narrows the previously reported RSMD1 locus to 3 centiMorgans.

Entities:  

Mesh:

Year:  2000        PMID: 10665485

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

Review 1.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

2.  Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: A case report.

Authors:  Yingyin Liang; Guidian Li; Songlin Chen; Rongxing He; Xiangxue Zhou; Yingming Chen; Xue Xu; Ronglan Zhu; Cheng Zhang
Journal:  Biomed Rep       Date:  2017-06-29

3.  Molecular mechanism of rigid spine with muscular dystrophy type 1 caused by novel mutations of selenoprotein N gene.

Authors:  Yuji Okamoto; Hiroshi Takashima; Itsuro Higuchi; Wataru Matsuyama; Masahito Suehara; Yasushi Nishihira; Akihiro Hashiguchi; Ryuki Hirano; Arlene R Ng; Masanori Nakagawa; Shuji Izumo; Mitsuhiro Osame; Kimiyoshi Arimura
Journal:  Neurogenetics       Date:  2006-06-15       Impact factor: 2.660

4.  Rigid Spine Syndrome among Children in Oman.

Authors:  Roshan Koul; Dilip Sankhla; Suad Al-Jahdhami; Renjith Mani; Rana A Rahim; Saif Al-Yaarubi; Hussein Al-Kindy; Khalid Al-Thihli; Amna Al-Futaisi
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

Review 5.  Selenoprotein N in skeletal muscle: from diseases to function.

Authors:  Perrine Castets; Alain Lescure; Pascale Guicheney; Valérie Allamand
Journal:  J Mol Med (Berl)       Date:  2012-04-14       Impact factor: 4.599

6.  Magnetic resonance imaging in muscular dystrophies.

Authors:  Luisa Politano; Giovanni Nigro
Journal:  Acta Myol       Date:  2015-12

Review 7.  The human selenoproteome: recent insights into functions and regulation.

Authors:  M A Reeves; P R Hoffmann
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

8.  Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle.

Authors:  Michael J Jurynec; Ruohong Xia; John J Mackrill; Derrick Gunther; Thomas Crawford; Kevin M Flanigan; Jonathan J Abramson; Michael T Howard; David Jonah Grunwald
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-19       Impact factor: 11.205

9.  A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy.

Authors:  Baijayanta Maiti; Sandrine Arbogast; Valérie Allamand; Mark W Moyle; Christine B Anderson; Pascale Richard; Pascale Guicheney; Ana Ferreiro; Kevin M Flanigan; Michael T Howard
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

Review 10.  Consensus statement on standard of care for congenital muscular dystrophies.

Authors:  Ching H Wang; Carsten G Bonnemann; Anne Rutkowski; Thomas Sejersen; Jonathan Bellini; Vanessa Battista; Julaine M Florence; Ulrike Schara; Pamela M Schuler; Karim Wahbi; Annie Aloysius; Robert O Bash; Christophe Béroud; Enrico Bertini; Kate Bushby; Ronald D Cohn; Anne M Connolly; Nicolas Deconinck; Isabelle Desguerre; Michelle Eagle; Brigitte Estournet-Mathiaud; Ana Ferreiro; Albert Fujak; Nathalie Goemans; Susan T Iannaccone; Patricia Jouinot; Marion Main; Paola Melacini; Wolfgang Mueller-Felber; Francesco Muntoni; Leslie L Nelson; Jes Rahbek; Susana Quijano-Roy; Caroline Sewry; Kari Storhaug; Anita Simonds; Brian Tseng; Jiri Vajsar; Andrea Vianello; Reinhard Zeller
Journal:  J Child Neurol       Date:  2010-11-15       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.